Portfolio
Our portfolio aims to eliminate >$25B USD of annual losses to producers caused by a handful of devastating diseases(1)
Estimated global annual losses to producers from necrotic enteritis (NE) to reach $8B USD by 2025 (1).
2015 annual losses from (NE) caused by Clostridium perfringens was estimated to be more than $6B USD globally, likely underestimated due to unreported subclinical disease (4,5).
Estimated global annual losses to producers from coccidiosis to reach $12B-$14M USD by 2025 (1).
2016 annual losses from Eimeria species causing coccidiosis in poultry estimated to be $11B USD (3).
Estimated global Annual losses to producers from Salmonella to reach $1B USD by 2025 (1).
A 2020 estimate showed Salmonella food-born illnesses derived from poultry cost Americans up to $2.8B USD annually (2).
Estimated global annual losses to producers from Vibrio parahaemolyticus to reach $2B USD by 2025 (1).
A 2013 estimate showed Early Mortality Syndrome (EMS) in white leg shrimp is caused by V. parahaemolyticus and resulted in $1B USD loss each year in Asia (6). Since EMS emergence in 2009, it has led to an estimated cumulative economic loss of $43B USD (7).
Estimated global annual losses to producers from White Spot Syndrome Virus (WSSV) to reach $2 billion USD by 2025 (1).
A 2012 estimate showed WSSV resulted in a cumulative loss of $8-14B USD since its emergence in the 1990’s (8).
Unencumbered and expanding IP
NovoBind's IP portfolio is unencumbered and completely proprietary, with the freedom to operate in its chosen field. Our technology is positioned for IP protection through patents, trade secrets on microorganisms, production, and applications as warranted.
NovoBind has published patents in the following areas:
Major Host
Pathogen
Patent ID
References
(1) Projected economic losses are estimates for the year 2025 based on previously published literature that accounts for mosaic modelling.
(2) Scharff, Robert. 2020. Food Attribution and Economic Cost Estimates for Meat- and Poultry-related Illnesses (https://doi.org/10.4315/JFP-19-548)
(3) Blake, D.P. et al. 2020. Re-calculating the cost of coccidiosis in chickens. Veterinary Research (https://doi.org/10.1186/s13567-020-00837-2
(4) Wade, B. & Keyburn, A. 2015. The true cost of necrotic enteritis. World Poultry. (https://www.poultryworld.net/poultry/the-true-cost-of-necrotic-enteritis/)
(5) Skinner et al 2010. An Economic Analysis of the Impact of Subclinical Necrotic Enteritis in Broiler Chickens. Avian Diseases. 54(4):1237-1240. (https://doi.org/10.1637/9399-052110-Reg.1)
(6) Disease Kills Shrimp Output, Pushes U.S Prices Higher (https://www.wsj.com/articles/SB10001424127887323998604578565201120674008)
(7) Kumar, V. et al. 2021. Acute hepatopancreatic necrosis disease (AHPND): Virulence, pathogenesis, and mitigation strategies in shrimp aquaculture. Toxins. Volume 13(8), Article 524. (https://www.mdpi.com/2072-6651/13/8/524)
(8) Stentiford, G. et al. 2012. Disease will limit future food supply from the global crustacean fishery and aquaculture sectors. Journal of Invertebrate Pathology. (https://doi.org/10.1016/j.jip.2012.03.013)